Tod Smeal
Chief Tech/Sci/R&D Officer chez CARDIFF ONCOLOGY, INC.
Fortune : - $ au 31/03/2024
Profil
Tod Smeal is currently the Chief Scientific Officer at Cardiff Oncology, Inc. He previously held positions as the Director-Oncology Research Unit at Pfizer Inc. from 2003 to 2015, the Chief Scientific Officer at Eli Lilly & Co. from 2015 to 2020, and the Chief Scientific Officer at Hexagon Bio, Inc. from 2020 to 2021.
Dr. Smeal obtained his undergraduate degree from the Massachusetts Institute of Technology and his doctorate degree from the University of California San Diego.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CARDIFF ONCOLOGY, INC.
-.--% | 07/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Tod Smeal
| Sociétés | Poste | Début |
|---|---|---|
| CARDIFF ONCOLOGY, INC. | Chief Tech/Sci/R&D Officer | 11/01/2022 |
Anciens postes connus de Tod Smeal
| Sociétés | Poste | Fin |
|---|---|---|
Hexagon Bio, Inc.
 Hexagon Bio, Inc. BiotechnologyHealth Technology Hexagon Bio, Inc. operates as a data-driven biotechnology company. It engages in mining of fungal genome data for drugs. The company was founded by Maureen E. Hillenmeyer, Brian T. Naughton, Colin James Bell Harvey and Yi Tang and is headquartered in Menlo Park, CA. | Chief Tech/Sci/R&D Officer | 01/01/2021 |
| ELI LILLY AND COMPANY | Chief Tech/Sci/R&D Officer | 01/01/2020 |
| PFIZER, INC. | Corporate Officer/Principal | 01/01/2015 |
Formation de Tod Smeal
| Massachusetts Institute of Technology | Undergraduate Degree |
| University of California San Diego | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| PFIZER, INC. | Health Technology |
| CARDIFF ONCOLOGY, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Hexagon Bio, Inc.
Hexagon Bio, Inc. BiotechnologyHealth Technology Hexagon Bio, Inc. operates as a data-driven biotechnology company. It engages in mining of fungal genome data for drugs. The company was founded by Maureen E. Hillenmeyer, Brian T. Naughton, Colin James Bell Harvey and Yi Tang and is headquartered in Menlo Park, CA. | Health Technology |
